Literature DB >> 10555351

Detection of three different types of 'Tropheryma whippelii' directly from clinical specimens by sequencing, single-strand conformation polymorphism (SSCP) analysis and type-specific PCR of their 16S-23S ribosomal intergenic spacer region.

H P Hinrikson1, F Dutly, S Nair, M Altwegg.   

Abstract

The 16S-23S rDNA intergenic spacer region of organisms identical with or closely related to 'Tropheryma whippelii', the uncultivated causative agent of Whipple's disease, was analysed directly from 38 clinical specimens of 28 patients using a specific nested PCR followed by direct sequencing. As compared to the reference sequence in public databases, two novel 'T. whippelii' spacer types were recognized. In the absence of DNA-DNA hybridization data it is uncertain whether the three types found represent subtypes of a single species or three different but closely related species. Methods were developed to detect all three variants by single-strand conformation polymorphism analysis and by type-specific PCR assays, thus allowing the screening of large numbers of specimens. Further studies may provide a clue to the possible associations between the type of infecting strain and the various clinical presentations of Whipple's disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10555351     DOI: 10.1099/00207713-49-4-1701

Source DB:  PubMed          Journal:  Int J Syst Bacteriol        ISSN: 0020-7713


  16 in total

Review 1.  Whipple's disease.

Authors:  F Fenollar; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

2.  Cloning and sequencing of a part of the heat shock protein 65 gene (hsp65) of "Tropheryma whippelii" and its use for detection of "T. whippelii" in clinical specimens by PCR.

Authors:  S Morgenegg; F Dutly; M Altwegg
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Evaluation of a specific nested PCR targeting domain III of the 23S rRNA gene of "Tropheryma whippelii" and proposal of a classification system for its molecular variants.

Authors:  H P Hinrikson; F Dutly; M Altwegg
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 4.  Whipple's disease and "Tropheryma whippelii".

Authors:  F Dutly; M Altwegg
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

5.  Whipple's Disease: Diagnostic Value of rpoB Gene PCR from Peripheral Blood Mononuclear Cells.

Authors:  Kathleen Weigt; Alexandra Wiessner; Annette Moter; Florence Fenollar; Didier Raoult; Kristina Allers; Thomas Schneider; Verena Moos
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

6.  Organization, structure, and variability of the rRNA operon of the Whipple's disease bacterium (Tropheryma whippelii).

Authors:  M Maiwald; A von Herbay; P W Lepp; D A Relman
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

Review 7.  Clinical Manifestations, Treatment, and Diagnosis of Tropheryma whipplei Infections.

Authors:  Ruben A V Dolmans; C H Edwin Boel; Miangela M Lacle; Johannes G Kusters
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

8.  Tropheryma whipplei in children with gastroenteritis.

Authors:  Didier Raoult; Florence Fenollar; Jean Marc Rolain; Philippe Minodier; Emmanuelle Bosdure; Wenjun Li; Jean Marc Garnier; Herve Richet
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

9.  Fourteen years of severe arthralgia in a man without gastrointestinal symptoms: atypical Whipple's disease.

Authors:  Fabiola Mancini; Serena Sbaragli; Gilberto Colivicchi; Antonio Cassone; Alessandra Ciervo
Journal:  J Clin Microbiol       Date:  2008-12-17       Impact factor: 5.948

10.  Validation of an rpoB gene PCR assay for detection of Tropheryma whipplei: 10 years' experience in a National Reference Laboratory.

Authors:  Annette Moter; Dinah Schmiedel; Annett Petrich; Alexandra Wiessner; Judith Kikhney; Thomas Schneider; Verena Moos; Ulf B Göbel; Udo Reischl
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.